Hopital Roger Salengro, CHRU de Lille

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Open Label Extension to Assess Long Term Safety and Efficacy of KL1333 in Patients With Primary Mitochondrial Disease	Nutritional and Metabolic Diseases, inborn mitochondrial metabolism disorder, metabolic disease	Recruiting	Phase 2	2026-09-16		NCT07514338
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Muscle Weakness, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease	Recruiting	Phase 2	2026-06-26		NCT05650229

Clinical trials